Raman-Tangella Vidya's Form 4 filing
Teladoc Health, Inc. (TDOC) · filed Aug 3, 2023
- Accession no.
- 0001477449-23-000021
- Filed
- Aug 3, 2023
- Trade date
- Aug 1-2, 2023
- Filing delay
- 2 days
- Rule 10b5-1 plan
- Not checked
This filing lists 2 non-derivative transactions and 1 derivative transaction. Open-market sales total $141.0K. It was filed 2 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Raman-Tangella VidyaCIK 0001918441 | Officer (CHIEF MEDICAL OFFICER) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Aug 1, 2023 | Common Stock | MOption exerciseAcquired | +10,244 | –F1 | – | 35,864 | Direct | |
| Aug 2, 2023 | Common Stock | SSaleDisposed | −5,215 | $27.03 | −$140,961.45 | 30,649 | Direct |
Derivative securities (Table II)
Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.
| Trade date | Security | Transaction | Underlying shares | Unit price | Value | Held after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Aug 1, 2023 | Common Stock | MOption exerciseDisposed | −10,244 | $0.00 | $0 | 71,708 | Direct |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
- F1
Restricted stock units convert to shares of TDOC common stock on a one-for-one basis.
Referenced by the price of 1 transaction in Table I.